Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Debt Ratio (2016 - 2025)

Plus Therapeutics has reported Debt Ratio over the past 16 years, most recently at 0.05 for Q4 2025.

  • Quarterly Debt Ratio fell 90.74% to 0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05 through Dec 2025, down 90.74% year-over-year, with the annual reading at 0.05 for FY2025, 90.74% down from the prior year.
  • Debt Ratio was 0.05 for Q4 2025 at Plus Therapeutics, down from 0.5 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.64 in Q1 2024 and troughed at 0.05 in Q4 2025.
  • The 5-year median for Debt Ratio is 0.32 (2021), against an average of 0.33.
  • Year-over-year, Debt Ratio soared 97.5% in 2024 and then tumbled 90.74% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.3 in 2021, then dropped by 24.88% to 0.23 in 2022, then surged by 54.48% to 0.35 in 2023, then soared by 42.15% to 0.5 in 2024, then tumbled by 90.74% to 0.05 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Debt Ratio are 0.05 (Q4 2025), 0.5 (Q4 2024), and 0.47 (Q3 2024).